Global Nonalcoholic Steatohepatitis Diagnostic Market Research Report 2025(Status and Outlook)

March 2025 | 232 pages | ID: G602543791FDEN
Bosson Research

Abstracts

Report Overview

Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver. It is part of a group of conditions called nonalcoholic fatty liver disease.

This report provides a deep insight into the global Nonalcoholic Steatohepatitis Diagnostic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nonalcoholic Steatohepatitis Diagnostic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nonalcoholic Steatohepatitis Diagnostic market in any manner.

Global Nonalcoholic Steatohepatitis Diagnostic Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Echosens

Prometheus Laboratories

GENFIT SA

Siemens Medical Solutions USA

Inc.

BioPredictive S.A.S

Quest Diagnostics Incorporated.

Meridian Bioscience

Inc.

Laboratory Corporation of America Holdings

Market Segmentation (by Type)

Serum Biomarkers

Hepatic Fibrosis Biomarkers

Oxidative Stress Biomarkers

Apoptosis Biomarkers

Others

Market Segmentation (by Application)

Pharma & CRO Industry

Hospitals

Academic Research Institutes

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Nonalcoholic Steatohepatitis Diagnostic Market
• Overview of the regional outlook of the Nonalcoholic Steatohepatitis Diagnostic Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nonalcoholic Steatohepatitis Diagnostic Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Nonalcoholic Steatohepatitis Diagnostic
1.2 Key Market Segments
  1.2.1 Nonalcoholic Steatohepatitis Diagnostic Segment by Type
  1.2.2 Nonalcoholic Steatohepatitis Diagnostic Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL NONALCOHOLIC STEATOHEPATITIS DIAGNOSTIC MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Nonalcoholic Steatohepatitis Diagnostic Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL NONALCOHOLIC STEATOHEPATITIS DIAGNOSTIC MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Nonalcoholic Steatohepatitis Diagnostic Product Life Cycle
3.3 Global Nonalcoholic Steatohepatitis Diagnostic Sales by Manufacturers (2020-2025)
3.4 Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Manufacturers (2020-2025)
3.5 Nonalcoholic Steatohepatitis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nonalcoholic Steatohepatitis Diagnostic Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Nonalcoholic Steatohepatitis Diagnostic Manufacturing Sites, Area Served, Product Type
3.8 Nonalcoholic Steatohepatitis Diagnostic Market Competitive Situation and Trends
  3.8.1 Nonalcoholic Steatohepatitis Diagnostic Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Nonalcoholic Steatohepatitis Diagnostic Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 NONALCOHOLIC STEATOHEPATITIS DIAGNOSTIC INDUSTRY CHAIN ANALYSIS

4.1 Nonalcoholic Steatohepatitis Diagnostic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF NONALCOHOLIC STEATOHEPATITIS DIAGNOSTIC MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Nonalcoholic Steatohepatitis Diagnostic Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Nonalcoholic Steatohepatitis Diagnostic Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL NONALCOHOLIC STEATOHEPATITIS DIAGNOSTIC MARKET SALES BY REGION

6.1 Global Nonalcoholic Steatohepatitis Diagnostic Sales by Region
  6.1.1 Global Nonalcoholic Steatohepatitis Diagnostic Sales by Region
  6.1.2 Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Region
6.2 Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Region
  6.2.1 Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Region
  6.2.2 Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Nonalcoholic Steatohepatitis Diagnostic Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Nonalcoholic Steatohepatitis Diagnostic Market Size by Type
7.3 North America Nonalcoholic Steatohepatitis Diagnostic Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Type
8.3 Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size by Type
9.3 Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Nonalcoholic Steatohepatitis Diagnostic Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Nonalcoholic Steatohepatitis Diagnostic Market Size by Type
10.3 South America Nonalcoholic Steatohepatitis Diagnostic Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Type
11.3 Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Application

12 NONALCOHOLIC STEATOHEPATITIS DIAGNOSTIC MARKET PRODUCTION BY REGION

12.1 Global Production of Nonalcoholic Steatohepatitis Diagnostic by Region(2020-2025)
12.2 Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Region (2020-2025)
12.3 Global Nonalcoholic Steatohepatitis Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Nonalcoholic Steatohepatitis Diagnostic Production
  12.4.1 North America Nonalcoholic Steatohepatitis Diagnostic Production Growth Rate (2020-2025)
  12.4.2 North America Nonalcoholic Steatohepatitis Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Nonalcoholic Steatohepatitis Diagnostic Production
  12.5.1 Europe Nonalcoholic Steatohepatitis Diagnostic Production Growth Rate (2020-2025)
  12.5.2 Europe Nonalcoholic Steatohepatitis Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Nonalcoholic Steatohepatitis Diagnostic Production (2020-2025)
  12.6.1 Japan Nonalcoholic Steatohepatitis Diagnostic Production Growth Rate (2020-2025)
  12.6.2 Japan Nonalcoholic Steatohepatitis Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Nonalcoholic Steatohepatitis Diagnostic Production (2020-2025)
  12.7.1 China Nonalcoholic Steatohepatitis Diagnostic Production Growth Rate (2020-2025)
  12.7.2 China Nonalcoholic Steatohepatitis Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)

13 NONALCOHOLIC STEATOHEPATITIS DIAGNOSTIC MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Type (2020-2033)
13.3 Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type (2020-2033)
13.4 Global Nonalcoholic Steatohepatitis Diagnostic Price by Type (2020-2033)

14 NONALCOHOLIC STEATOHEPATITIS DIAGNOSTIC MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Nonalcoholic Steatohepatitis Diagnostic Market Sales by Application (2020-2033)
14.3 Global Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Application (2020-2033)
14.4 Global Nonalcoholic Steatohepatitis Diagnostic Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Echosens
  15.1.1 Echosens Basic Information
  15.1.2 Echosens Nonalcoholic Steatohepatitis Diagnostic Product Overview
  15.1.3 Echosens Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
  15.1.4 Echosens Business Overview
  15.1.5 Echosens SWOT Analysis
  15.1.6 Echosens Recent Developments
15.2 Prometheus Laboratories
  15.2.1 Prometheus Laboratories Basic Information
  15.2.2 Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Product Overview
  15.2.3 Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
  15.2.4 Prometheus Laboratories Business Overview
  15.2.5 Prometheus Laboratories SWOT Analysis
  15.2.6 Prometheus Laboratories Recent Developments
15.3 GENFIT SA
  15.3.1 GENFIT SA Basic Information
  15.3.2 GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Product Overview
  15.3.3 GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
  15.3.4 GENFIT SA Business Overview
  15.3.5 GENFIT SA SWOT Analysis
  15.3.6 GENFIT SA Recent Developments
15.4 Siemens Medical Solutions USA
  15.4.1 Siemens Medical Solutions USA Basic Information
  15.4.2 Siemens Medical Solutions USA Nonalcoholic Steatohepatitis Diagnostic Product Overview
  15.4.3 Siemens Medical Solutions USA Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
  15.4.4 Siemens Medical Solutions USA Business Overview
  15.4.5 Siemens Medical Solutions USA Recent Developments
15.5 Inc.
  15.5.1 Inc. Basic Information
  15.5.2 Inc. Nonalcoholic Steatohepatitis Diagnostic Product Overview
  15.5.3 Inc. Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
  15.5.4 Inc. Business Overview
  15.5.5 Inc. Recent Developments
15.6 BioPredictive S.A.S
  15.6.1 BioPredictive S.A.S Basic Information
  15.6.2 BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Product Overview
  15.6.3 BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
  15.6.4 BioPredictive S.A.S Business Overview
  15.6.5 BioPredictive S.A.S Recent Developments
15.7 Quest Diagnostics Incorporated.
  15.7.1 Quest Diagnostics Incorporated. Basic Information
  15.7.2 Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Product Overview
  15.7.3 Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
  15.7.4 Quest Diagnostics Incorporated. Business Overview
  15.7.5 Quest Diagnostics Incorporated. Recent Developments
15.8 Meridian Bioscience
  15.8.1 Meridian Bioscience Basic Information
  15.8.2 Meridian Bioscience Nonalcoholic Steatohepatitis Diagnostic Product Overview
  15.8.3 Meridian Bioscience Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
  15.8.4 Meridian Bioscience Business Overview
  15.8.5 Meridian Bioscience Recent Developments
15.9 Inc.
  15.9.1 Inc. Basic Information
  15.9.2 Inc. Nonalcoholic Steatohepatitis Diagnostic Product Overview
  15.9.3 Inc. Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
  15.9.4 Inc. Business Overview
  15.9.5 Inc. Recent Developments
15.10 Laboratory Corporation of America Holdings
  15.10.1 Laboratory Corporation of America Holdings Basic Information
  15.10.2 Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Product Overview
  15.10.3 Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
  15.10.4 Laboratory Corporation of America Holdings Business Overview
  15.10.5 Laboratory Corporation of America Holdings Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nonalcoholic Steatohepatitis Diagnostic Market Size Comparison by Region (M USD)
Table 5. Global Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Nonalcoholic Steatohepatitis Diagnostic Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Nonalcoholic Steatohepatitis Diagnostic Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonalcoholic Steatohepatitis Diagnostic as of 2024)
Table 10. Global Market Nonalcoholic Steatohepatitis Diagnostic Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Nonalcoholic Steatohepatitis Diagnostic Manufacturing Sites and Area Served
Table 12. Manufacturers Nonalcoholic Steatohepatitis Diagnostic Product Type
Table 13. Global Nonalcoholic Steatohepatitis Diagnostic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Nonalcoholic Steatohepatitis Diagnostic Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Nonalcoholic Steatohepatitis Diagnostic Sales by Region (2020-2025) & (K Units)
Table 25. Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Region (2020-2025)
Table 26. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 27. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Region (2020-2025)
Table 28. North America Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2020-2033) & (M USD)
Table 29. North America Nonalcoholic Steatohepatitis Diagnostic Sales by Country (2020-2033) & (K Units)
Table 30. North America Nonalcoholic Steatohepatitis Diagnostic Sales by Type (K Units)
Table 31. North America Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (M USD)
Table 32. North America Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) by Type (2020-2033)
Table 33. North America Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Type (2020-2033)
Table 34. North America Nonalcoholic Steatohepatitis Diagnostic Sales by Application (K Units)
Table 35. North America Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (M USD)
Table 36. North America Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) by Application (2020-2033)
Table 37. North America Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Application (2020-2033)
Table 38. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2020-2033) & (M USD)
Table 39. Europe Nonalcoholic Steatohepatitis Diagnostic Sales by Country (2020-2033) & (K Units)
Table 40. Europe Nonalcoholic Steatohepatitis Diagnostic Sales by Type (K Units)
Table 41. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (M USD)
Table 42. Europe Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) by Type (2020-2033)
Table 43. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Type (2020-2033)
Table 44. Europe Nonalcoholic Steatohepatitis Diagnostic Sales by Application (K Units)
Table 45. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (M USD)
Table 46. Europe Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) by Application (2020-2033)
Table 47. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Application (2020-2033)
Table 48. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 49. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Sales by Country (2020-2025) & (K Units)
Table 50. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Sales by Type (K Units)
Table 51. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (M USD)
Table 52. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) by Type (2020-2033)
Table 53. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Type (2020-2025)
Table 54. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Sales by Application (K Units)
Table 55. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (M USD)
Table 56. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) by Application (2020-2033)
Table 57. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Application (2020-2025)
Table 58. South America Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2020-2033) & (M USD)
Table 59. South America Nonalcoholic Steatohepatitis Diagnostic Sales by Country (2020-2033) & (K Units)
Table 60. South America Nonalcoholic Steatohepatitis Diagnostic Sales by Type (K Units)
Table 61. South America Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (M USD)
Table 62. South America Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) by Type (2020-2033)
Table 63. South America Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Type (2020-2033)
Table 64. South America Nonalcoholic Steatohepatitis Diagnostic Sales by Application (K Units)
Table 65. South America Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (M USD)
Table 66. South America Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) by Application (2020-2033)
Table 67. South America Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Application (2020-2033)
Table 68. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2020-2033) & (M USD)
Table 69. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Sales by Country (2020-2033) & (K Units)
Table 70. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Sales by Type (K Units)
Table 71. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (M USD)
Table 72. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) by Type (2020-2033)
Table 73. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Type (2020-2033)
Table 74. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Sales by Application (K Units)
Table 75. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (M USD)
Table 76. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) by Application (2020-2033)
Table 77. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Application (2020-2033)
Table 78. Global Nonalcoholic Steatohepatitis Diagnostic Production (K Units) by Region(2020-2025)
Table 79. Global Nonalcoholic Steatohepatitis Diagnostic Revenue (US$ Million) by Region (2020-2025)
Table 80. Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Region (2020-2025)
Table 81. Global Nonalcoholic Steatohepatitis Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. North America Nonalcoholic Steatohepatitis Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Europe Nonalcoholic Steatohepatitis Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Japan Nonalcoholic Steatohepatitis Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. China Nonalcoholic Steatohepatitis Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Global Nonalcoholic Steatohepatitis Diagnostic Sales by Type (K Units)
Table 87. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (M USD)
Table 88. Global Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) by Type (2020-2033)
Table 89. Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Type (2020-2033)
Table 90. Global Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Type (2020-2033)
Table 91. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Share by Type (2020-2033)
Table 92. Global Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) by Application
Table 93. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Application(M USD)
Table 94. Global Nonalcoholic Steatohepatitis Diagnostic Sales by Application (2020-2033) & (K Units)
Table 95. Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Application (2020-2033)
Table 96. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2020-2033) & (M USD)
Table 97. Global Nonalcoholic Steatohepatitis Diagnostic Market Share by Application (2020-2033)
Table 98. Global Nonalcoholic Steatohepatitis Diagnostic Sales Growth Rate by Application (2020-2033)
Table 99. Echosens Basic Information
Table 100. Echosens Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 101. Echosens Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Echosens Business Overview
Table 103. Echosens SWOT Analysis
Table 104. Echosens Recent Developments
Table 105. Prometheus Laboratories Basic Information
Table 106. Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 107. Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Prometheus Laboratories Business Overview
Table 109. Prometheus Laboratories SWOT Analysis
Table 110. Prometheus Laboratories Recent Developments
Table 111. GENFIT SA Basic Information
Table 112. GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 113. GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. GENFIT SA Business Overview
Table 115. GENFIT SA SWOT Analysis
Table 116. GENFIT SA Recent Developments
Table 117. Siemens Medical Solutions USA Basic Information
Table 118. Siemens Medical Solutions USA Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 119. Siemens Medical Solutions USA Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Siemens Medical Solutions USA Business Overview
Table 121. Siemens Medical Solutions USA Recent Developments
Table 122. Inc. Basic Information
Table 123. Inc. Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 124. Inc. Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Inc. Business Overview
Table 126. Inc. Recent Developments
Table 127. BioPredictive S.A.S Basic Information
Table 128. BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 129. BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. BioPredictive S.A.S Business Overview
Table 131. BioPredictive S.A.S Recent Developments
Table 132. Quest Diagnostics Incorporated. Basic Information
Table 133. Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 134. Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Quest Diagnostics Incorporated. Business Overview
Table 136. Quest Diagnostics Incorporated. Recent Developments
Table 137. Meridian Bioscience Basic Information
Table 138. Meridian Bioscience Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 139. Meridian Bioscience Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Meridian Bioscience Business Overview
Table 141. Meridian Bioscience Recent Developments
Table 142. Inc. Basic Information
Table 143. Inc. Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 144. Inc. Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. Inc. Business Overview
Table 146. Inc. Recent Developments
Table 147. Laboratory Corporation of America Holdings Basic Information
Table 148. Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 149. Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 150. Laboratory Corporation of America Holdings Business Overview
Table 151. Laboratory Corporation of America Holdings Recent Developments
List of Figures
Figure 1. Product Picture of Nonalcoholic Steatohepatitis Diagnostic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD), 2024-2033
Figure 5. Global Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) (2020-2033)
Figure 6. Global Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nonalcoholic Steatohepatitis Diagnostic Product Life Cycle
Figure 13. Nonalcoholic Steatohepatitis Diagnostic Sales Share by Manufacturers in 2024
Figure 14. Global Nonalcoholic Steatohepatitis Diagnostic Revenue Share by Manufacturers in 2024
Figure 15. Nonalcoholic Steatohepatitis Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Nonalcoholic Steatohepatitis Diagnostic Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nonalcoholic Steatohepatitis Diagnostic Revenue in 2024
Figure 18. Industry Chain Map of Nonalcoholic Steatohepatitis Diagnostic
Figure 19. Global Nonalcoholic Steatohepatitis Diagnostic Market PEST Analysis
Figure 20. Global Nonalcoholic Steatohepatitis Diagnostic Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Region (2020-2025)
Figure 26. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Region (2020-2025)
Figure 27. North American Market Snapshot
Figure 28. North America Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 29. North America Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 30. North America Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Country
Figure 31. USA Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 32. USA Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 33. Canada Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) and Growth Rate (2020-2033)
Figure 34. Canada Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) and Growth Rate (2020-2033)
Figure 35. Mexico Nonalcoholic Steatohepatitis Diagnostic Sales (Units) and Growth Rate (2020-2033)
Figure 36. Mexico Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. North America Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD)by Type
Figure 38. North America Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Application
Figure 39. Europe Market Snapshot
Figure 40. Europe Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 41. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 42. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Country
Figure 43. Germany Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 44. Germany Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 45. France Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. France Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. U.K. Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. U.K. Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 49. Italy Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. Italy Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 51. Spain Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Spain Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Type
Figure 54. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Application
Figure 55. Asia-Pacific Market Snapshot
Figure 56. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 57. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Country
Figure 59. China Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. China Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Japan Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Japan Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. South Korea Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. South Korea Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. India Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. India Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. Southeast Asia Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. Southeast Asia Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Type
Figure 70. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Application
Figure 71. South America Market Snapshot
Figure 72. South America Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 73. South America Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 74. South America Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Country
Figure 75. Brazil Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 76. Brazil Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 77. Argentina Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Argentina Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Columbia Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Columbia Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. South America Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Type
Figure 82. South America Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Application
Figure 83. Middle East and Africa Market Snapshot
Figure 84. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 85. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 86. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Country
Figure 87. Saudi Arabia Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 88. Saudi Arabia Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 89. UAE Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. UAE Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. Egypt Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. Egypt Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Nigeria Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Nigeria Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. South Africa Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. South Africa Nonalcoholic Steatohepatitis Diagnostic Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Type
Figure 98. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Application
Figure 99. Global Nonalcoholic Steatohepatitis Diagnostic Production Market Share by Region (2020-2025)
Figure 100. North America Nonalcoholic Steatohepatitis Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 101. Europe Nonalcoholic Steatohepatitis Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 102. Japan Nonalcoholic Steatohepatitis Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 103. China Nonalcoholic Steatohepatitis Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 104. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 105. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (M USD)
Figure 106. Sales Market Share of Nonalcoholic Steatohepatitis Diagnostic by Type (2020-2033)
Figure 107. Sales Market Share of Nonalcoholic Steatohepatitis Diagnostic by Type in 2024
Figure 108. Market Size Share of Nonalcoholic Steatohepatitis Diagnostic by Type (2020-2033)
Figure 109. Market Size Share of Nonalcoholic Steatohepatitis Diagnostic by Type in 2024
Figure 110. Global Nonalcoholic Steatohepatitis Diagnostic Price (USD/Unit) by Type (2020-2033)
Figure 111. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 112. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Application(M USD)
Figure 113. Global Nonalcoholic Steatohepatitis Diagnostic Market Share by Application
Figure 114. Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Application (2020-2033)
Figure 115. Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Application in 2024
Figure 116. Global Nonalcoholic Steatohepatitis Diagnostic Market Share by Application (2020-2033)
Figure 117. Global Nonalcoholic Steatohepatitis Diagnostic Market Share by Application in 2024
Figure 118. Global Nonalcoholic Steatohepatitis Diagnostic Sales Growth Rate by Application (2020-2033)